Inhibition of ER stress–associated IRE-1/XBP-1 pathway reduces leukemic cell survival
出版年份 2014 全文链接
标题
Inhibition of ER stress–associated IRE-1/XBP-1 pathway reduces leukemic cell survival
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume 124, Issue 6, Pages 2585-2598
出版商
American Society for Clinical Investigation
发表日期
2014-05-08
DOI
10.1172/jci73448
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthesis of Novel Tricyclic Chromenone-Based Inhibitors of IRE-1 RNase Activity
- (2014) Sujeewa Ranatunga et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
- (2013) Jan A. Burger et al. LEUKEMIA & LYMPHOMA
- Selective inhibition of the unfolded protein response: targeting catalytic sites for Schiff base modification
- (2013) Susana M. Tomasio et al. Molecular BioSystems
- Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
- (2013) Michael L. Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis
- (2012) N. Capitani et al. BLOOD
- Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice
- (2012) C. L. Kriss et al. BLOOD
- Blockade of XBP1 splicing by inhibition of IRE1 is a promising therapeutic option in multiple myeloma
- (2012) N. Mimura et al. BLOOD
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
- (2012) R. Lapalombella et al. BLOOD
- The B-cell receptor signaling pathway as a therapeutic target in CLL
- (2012) J. A. Woyach et al. BLOOD
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions
- (2012) M T S Bertilaccio et al. LEUKEMIA
- The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule
- (2012) B. C. S. Cross et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
- (2011) S. Ponader et al. BLOOD
- Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease
- (2011) Kori Volkmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the E - TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling
- (2010) M. Suljagic et al. BLOOD
- 17-DMAG targets the nuclear factor- B family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
- (2010) E. Hertlein et al. BLOOD
- Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma
- (2010) I. Papandreou et al. BLOOD
- Flavonol Activation Defines an Unanticipated Ligand-Binding Site in the Kinase-RNase Domain of IRE1
- (2010) R. Luke Wiseman et al. MOLECULAR CELL
- The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
- (2009) David M. Lucas et al. BLOOD
- XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells
- (2009) Chih-Chi Andrew Hu et al. EMBO JOURNAL
- The TCL1 mouse as a model for chronic lymphocytic leukemia
- (2009) Terry J. Hamblin LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search